2010
DOI: 10.1111/j.1530-0277.2009.01114.x
|View full text |Cite
|
Sign up to set email alerts
|

Phosphodiesterase Type 4 Inhibition Does Not Restore Ocular Dominance Plasticity in a Ferret Model of Fetal Alcohol Spectrum Disorders

Abstract: There is growing evidence that deficits in neuronal plasticity account for some of the neurological problems observed in fetal alcohol spectrum disorders (FASD). Recently, we showed that early alcohol exposure results in a permanent impairment in visual cortex ocular dominance (OD) plasticity in a ferret model of FASD. This disruption can be reversed, however, by treating animals with a Phosphodiesterase (PDE) type 1 inhibitor long after the period of alcohol exposure. Because the mammalian brain presents diff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 49 publications
(82 reference statements)
0
4
0
Order By: Relevance
“…Importantly, while cross talks between the cascades exist it is safe to say the CREB and SRF can be preferentially activated by cAMP and cGMP respectively. Recently, we discovered that, contrary to what was observed with vinpocetine, Rolipram, a PDE type 4 inhibitor failed to restore OD plasticity in the ferret model of FASD (Krahe et al, 2010). Since Rolipram increases only cAMP levels and not cGMP, one may suggest that the restoration of plasticity seen earlier is due to SRF activation.…”
Section: Introductionmentioning
confidence: 76%
“…Importantly, while cross talks between the cascades exist it is safe to say the CREB and SRF can be preferentially activated by cAMP and cGMP respectively. Recently, we discovered that, contrary to what was observed with vinpocetine, Rolipram, a PDE type 4 inhibitor failed to restore OD plasticity in the ferret model of FASD (Krahe et al, 2010). Since Rolipram increases only cAMP levels and not cGMP, one may suggest that the restoration of plasticity seen earlier is due to SRF activation.…”
Section: Introductionmentioning
confidence: 76%
“…Inhibition of PDE1 by vinpocetine reversed alcohol exposure-related cortical deficits, rescuing ocular dominance plasticity in ferrets and mice (Lantz, Wang, & Medina, 2012; Medina, Krahe, & Ramoa, 2006) and preventing Morris water maze acquisition impairments in rats (Filgueiras, Krahe, & Medina, 2010). Similar improvement of fetal alcohol-related deficits in ocular dominance plasticity can be generated by co-administration of inhibitors to PDE4 and PDE5, but not by treatment with either inhibitor alone (Krahe, Paul, & Medina, 2010; Lantz et al, 2012), implying that PDE1 inhibitors improve fetal alcohol-related pathology through coordinated elevations in cAMP and cGMP. It is of interest for future investigations to determine whether PDE1 inhibitors similarly reduce cognitive deficits due to excessive alcohol consumption in adulthood, as well as whether PDE1 plays a role in patterning alcohol intake, a function now well established for PDE4.…”
Section: Phosphodiesterase Regulation Of Alcohol Intakementioning
confidence: 90%
“…In contrast to the results obtaining with PD1 inhibition, the PDE4 inhibitor rolipram, which acts specifically on the cAMP cascade (Beavo, 1995), failed to restore OD plasticity in the ferret model of FASD even when tested with different doses (0.5 mg/kg, 1.25 mg/kg and 2.5 mg/kg) (Krahe et al, 2010). Because of the distinct results obtained with rolipram (acting specifically on cAMP) and vinpocetine (acting on both cAMP and cGMP) it is possible that the positive effects of PDE1 inhibitors are due to activation of the cGMP cascade.…”
Section: Introductionmentioning
confidence: 87%